Top

Journal of Neurology

Published in:

01-02-2016 | Letter to the Editors

Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report

Authors: Nicolas Mélé, Charlotte Hautefort, Alain Toledano, Jean-Yves Delattre, Dimitri Psimaras

Published in: Journal of Neurology | Issue 2/2016

Excerpt

Dear Sirs, …

Wong A (2007) An update on opsoclonus. Curr Opin Neurol 20(1):25–31CrossRefPubMed

Bataller L, Graus F, Saiz A, Vilchez JJ, Spanish Opsoclonus-Myoclonus Study Group (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain J Neurol 124(Pt 2):437–443CrossRef

Klaas JP, Ahlskog JE, Pittock SJ, Matsumoto JY, Aksamit AJ, Bartleson JD et al (2012) Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol 69(12):1598–1607CrossRefPubMed

Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung N-KV, Dalmau J (2003) Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol 53(3):347–353CrossRefPubMed

Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J (2001) Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol 50(3):339–348CrossRefPubMed

Wong AM, Musallam S, Tomlinson RD, Shannon P, Sharpe JA (2001) Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates. J Neurol Sci 189(1–2):71–81CrossRefPubMed

Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B et al (2004) Clinical analysis of anti-Ma2-associated encephalitis. Brain J Neurol 127(Pt 8):1831–1844CrossRef

Biotti D, Viaccoz A, Olivier N, Tilikete C, Rogemond V, Honnorat J et al (2012) Opsoclonus, limbic encephalitis, anti-Ma2 antibodies and gastric adenocarcinoma. Eur J Neurol Off J Eur Fed Neurol Soc 19(12):e144–e145

Jen JC, Lopez I, Baloh RW (2012) Opsoclonus: clinical and immunological features. J Neurol Sci 320(1–2):61–65CrossRefPubMed

10.

Hasegawa S, Matsushige T, Kajimoto M, Inoue H, Momonaka H, Oka M et al (2015) A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children. Brain Dev 37(7):656–660CrossRefPubMed

11.

Graus F, Saiz A, Dalmau J (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257(4):509–517CrossRefPubMed

12.

Armangue T, Titulaer MJ, Sabater L, Pardo-Moreno J, Gresa-Arribas N, Barbero-Bordallo N et al (2014) A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol 75(3):435–441CrossRefPubMed

13.

Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75(8):1135–1140CrossRefPubMedPubMedCentral

Title: Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report
Authors: Nicolas Mélé
Charlotte Hautefort
Alain Toledano
Jean-Yves Delattre
Dimitri Psimaras
Publication date: 01-02-2016
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 2/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-015-8012-0

At a glance: The STEP trials

Springer Medicine

Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2016

Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia

Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population

Predictors of outcome in HSV encephalitis

Improvement of lateral axial dystonia following prismatic correction of oculomotor control disorders in Parkinson’s disease

Defining the phenotype of restless legs syndrome/Willis–Ekbom disease (RLS/WED): a clinical and polysomnographic study

Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis